Actavis-Forest Bid Shines Light on Valeant Next: Real M&A

Actavis Plc’s purchase of Forest Laboratories Inc. accelerates a pharmaceutical merger wave that stands to engulf even more drugmakers.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.